GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | |
PROFIT vs RISK RATING 1..100 | 46 | |
SMR RATING 1..100 | 34 | |
PRICE GROWTH RATING 1..100 | 55 | |
P/E GROWTH RATING 1..100 | 53 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| EFAV | GSK | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 66% | N/A |
| Stochastic ODDS (%) | 3 days ago 78% | 3 days ago 47% |
| Momentum ODDS (%) | 3 days ago 62% | 3 days ago 67% |
| MACD ODDS (%) | 3 days ago 64% | 3 days ago 71% |
| TrendWeek ODDS (%) | 3 days ago 73% | 3 days ago 54% |
| TrendMonth ODDS (%) | 3 days ago 76% | 3 days ago 52% |
| Advances ODDS (%) | 6 days ago 78% | 11 days ago 64% |
| Declines ODDS (%) | 4 days ago 71% | 3 days ago 54% |
| BollingerBands ODDS (%) | 5 days ago 74% | 3 days ago 75% |
| Aroon ODDS (%) | 3 days ago 75% | 3 days ago 41% |
A.I.dvisor indicates that over the last year, EFAV has been loosely correlated with RIO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if EFAV jumps, then RIO could also see price increases.
| Ticker / NAME | Correlation To EFAV | 1D Price Change % | ||
|---|---|---|---|---|
| EFAV | 100% | +0.68% | ||
| RIO - EFAV | 50% Loosely correlated | +0.10% | ||
| SAN - EFAV | 49% Loosely correlated | +0.98% | ||
| RTO - EFAV | 44% Loosely correlated | +0.44% | ||
| GSK - EFAV | 43% Loosely correlated | -0.83% | ||
| CCEP - EFAV | 42% Loosely correlated | +1.42% | ||
More | ||||